Dr. Mark Mullen welcomes Dr. Christine Crawford, Chief Medical Officer at the National Alliance on Mental Illness (NAMI) and author of You Are Not Alone: For Parents and Caregivers, alongside Steve Hoffmann, Senior Vice President and Chief Preclinical Officer at the Foundation for the National Institutes of Health (FNIH). Dr. Crawford discusses NAMI’s mission and its 650 chapters nationwide, the concept of the “distress radius” as a framework for identifying when a child’s behavioral changes warrant professional evaluation, and practical strategies for engaging skeptical patients and families through primary care. She also highlights dialectical behavioral therapy (DBT) as a broadly applicable clinical tool and underscores the importance of evidence-based education for patients and caregivers navigating the mental health system.
The conversation then shifts to Steve Hoffmann’s work at the FNIH, including the newly launching Multimodal Assessment and Phenotyping in Depression (MAPD) study, a longitudinal, multi-site initiative designed to identify biological, clinical, and digital biomarkers associated with depression subtypes. Hoffmann outlines the study’s design, including neuroimaging, genetic testing, digital wearables, and patient-reported outcomes, with the goal of moving depression treatment away from a trial-and-error model toward a precision medicine approach. Dr. Crawford and Hoffmann both emphasize the importance of including patient voices in research design, drawing parallels to the foundational impact of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) on that field.
Takeaways:
The “distress radius” framework encourages parents to evaluate whether a child’s behavioral changes extend beyond the home into school, social, and extracurricular settings as a signal for further evaluation.
NAMI operates 650 chapters nationwide and offers peer-led support groups and educational workshops that clinicians can use as a clinical resource for patients and families.
Dialectical behavioral therapy (DBT) skills, including emotional regulation and mindfulness techniques, have broad applicability beyond borderline personality disorder and may benefit general populations.
The MAPD study aims to identify multimodal biomarkers, including neuroimaging, genetic, sleep, and digital data, to enable more precise, individualized depression treatment selection.
Engaging primary care providers early in the mental health conversation can reduce reliance on long specialist wait lists and help identify safety concerns sooner.
SUPPORT OUR PARTNERS: SimplePractice.com/bootcamp (Now with AI documentation! Exclusive 7 day free trial and 50% off four months)
Learn more and get transcripts for EVERY episode at
For Sales Inquiries & Ad Rates, Please Contact:Sales@Human-Content.Com
Connect with HumanContent on Socials: @humancontentpods
Produced by: Human Content
Learn more about your ad choices. Visit megaphone.fm/adchoices
Chapters:
00:00 Meet the Guests
00:58 What NAMI Does
02:31 Why NAMI Matters
04:24 Why Write You Are Not Alone
05:38 Building a Parent Roadmap
09:08 Distress Radius Warning Signs
12:46 NAMI as a Clinical Resource
18:37 Skeptical Patients and Primary Care
23:29 DBT Skills Everyone Needs
26:56 Sponsor Break
29:26 What Is the FNIH
33:32 MAPD Mapping Depression
46:40 Hopes and Takeaways
source